Abp. Van Kuilenburg et al., Pitfalls in the diagnosis of patients with a partial dihydropyrimidine dehydrogenase deficiency, CLIN CHEM, 46(1), 2000, pp. 9-17
Background: Dihydropyrimidine dehydrogenase (DPD) catalyzes the degradation
of thymine, uracil, and the chemotherapeutic drug 5-fluorouracil. To ident
ify patients suffering from complete or partial DPD deficiency and to ident
ify pitfalls that can preclude the proper diagnosis of patients with partia
l DPD deficiency, a sensitive and accurate assay is necessary.
Methods: The activity of DPD was measured using [4-C-14]thymine followed by
separation of substrate and products with reversed-phase HPLC with on-line
detection of the radioactivity.
Results: Complete baseline separation of radiolabeled thymine and all degra
dation products was achieved within 15 min. The detection limit for dihydro
thymine was 0.4 pmol. In lymphocytes, the DPD activity deviated from linear
ity at low protein concentrations (<0.2 g/L). Profoundly decreased activity
of DPD was detected in the peripheral blood mononuclear cells (PBM cells)
of two tumor patients when measured at low protein concentrations. Low DPD
activity comparable to that observed in obligate heterozygotes was initiall
y detected in PBM cells, containing substantial amounts of myeloid cells, f
rom a patient suffering from 5-fluorouracil toxicity. However, after the pa
tient experienced full clinical recovery, normal DPD activity was observed
in the PBM cells. No significant differences in DPD activity were observed
between exponentially growing fibroblasts and those at confluence. The rang
e of DPD activities of obligate heterozygotes overlaps the range of DPD act
ivities of controls.
Conclusions: The low activity of DPD measured in PBM cells containing myelo
id cells or that measured at a low protein concentration in the assay mixtu
re is not indicative of heterozygosity for a mutant DPD allele. Although fi
broblasts are suitable to establish a complete deficiency of DPD, unambiguo
us detection of heterozygotes is not possible.
(C) 2000 American Association for Clinical Chemistry.